Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

PloS one - 1 Jan 2013

Thompson Ella R, Rowley Simone M, Sawyer Sarah, kConfab, Eccles Diana M, Trainer Alison H, Mitchell Gillian, James Paul A, Campbell Ian G

Abstract excerpt

Mutations in RAD51D have been associated with an increased risk of hereditary ovarian cancer and although they have been observed in the context of breast and ovarian cancer families, the association with breast cancer is unclear. The aim of this current study was to validate the reported association of RAD51D with ovarian cancer and assess for an association with breast cancer. We screened for RAD51D mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Family

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Loss of Heterozygosity

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23372765
DOI: 10.1371/journal.pone.0054772
PMCID: PMC3555982

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.PMID 23372765Read ↗

Germline mutations in RAD51D confer susceptibility to ovarian cancer.Semantic proximity Read ↗

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.Semantic proximity Read ↗

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.Semantic proximity Read ↗

Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.Semantic proximity Read ↗

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.Semantic proximity Read ↗

Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer.Semantic proximity Read ↗

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patientsSemantic proximity Read ↗

A decade of RAD51C/D: Germline pathogenic variants and their phenotypic landscapeSemantic proximity Read ↗

A decade of RAD51C and RAD51D germline variants in cancer.Semantic proximity Read ↗

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.Semantic proximity Read ↗

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.Semantic proximity Read ↗

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.